Related Experiment Video
Updated: Feb 22, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Complications during the treatment of diabetic foot osteomyelitis
Suzanne A V van Asten1, Moez Mithani2, Edgar J G Peters3
1Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, VU Medical Center, Amsterdam, The Netherlands.
Aim:
To identify complications of medical treatment in patients with diabetic foot osteomyelitis (DFO).
Methods:
We reviewed 143 records of consecutive patients admitted with DFO, confirmed by bone histopathology or culture. Complications monitored included acute kidney injuries (AKI), development of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE), gastrointestinal complications, and venous catheter related complications during a 12months follow-up period.
Results:
Forty-seven AKI episodes were reported during follow-up; half occurred during the first hospitalization with involvement of antimicrobial therapy in 14 events (29.8%). Patients with AKI were more likely to have recurrent ulcerations (69.2% vs. 45.2%, p=0.02), recurrent infections (38.5% vs. 17.3%, p=0.01), and recurrent hospitalizations (43.6% vs. 28.8%, p=0.02) during follow-up. Only 14 MRSA isolates were found in bone samples at baseline (9.8%). Resistant strains of MRSA and VRE were identified in twenty-one patients (14.7%) during follow-up. Patients re-hospitalized for infection were more likely to have resistant bacterial strains (52.6% vs. 25.8%, p=0.02).
Conclusions:
In this study, the rates of VRE and MRSA in bone biopsies of patients with DFO were lower than in previous reports. Acute kidney injury occurred frequently in our patient population but might not be associated with antibiotic exposure.
Insights
Diabetic foot osteomyelitis (DFO) patients frequently experienced acute kidney injury (AKI), which was linked to worse outcomes. Rates of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) were lower than previously reported.
Area of Science:
- Infectious Diseases
- Nephrology
- Diabetology
Background:
- Diabetic foot osteomyelitis (DFO) is a serious complication of diabetes, often requiring prolonged treatment.
- Medical interventions for DFO can lead to various complications, impacting patient outcomes.
- Understanding these complications is crucial for optimizing DFO management.
Purpose of the Study:
- To identify and analyze complications arising from medical treatments in patients diagnosed with diabetic foot osteomyelitis (DFO).
- To assess the incidence of acute kidney injury (AKI), antimicrobial-resistant infections (MRSA, VRE), and catheter-related issues in DFO patients.
- To explore associations between complications and patient outcomes during a 12-month follow-up.
Main Methods:
- A retrospective review of 143 patients with histopathology or culture-confirmed DFO.
- Monitoring for acute kidney injuries (AKI), development of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).
- Tracking gastrointestinal and venous catheter-related complications over a 12-month follow-up period.
Main Results:
- Forty-seven episodes of AKI were recorded, with half occurring during initial hospitalization, 29.8% linked to antimicrobial therapy.
- Patients experiencing AKI showed higher rates of recurrent ulcerations (69.2%), infections (38.5%), and hospitalizations (43.6%).
- Baseline MRSA rates in bone were 9.8%; resistant strains (MRSA/VRE) were found in 14.7% during follow-up, more common in re-hospitalized patients (52.6%).
Conclusions:
- DFO patients frequently developed AKI, associated with poorer outcomes, though not definitively linked to antibiotic exposure.
- The incidence of MRSA and VRE in DFO bone biopsies was lower than previously documented.
- Effective management of DFO requires vigilant monitoring for complications like AKI and resistant infections.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Peripheral Artery Disease IV: Nursing Management
Hemodialysis II: Procedure and Complications

